Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Treatment Clinical Trials for Adrenal Cortex Cancer

Review the adrenal cortex cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-12 of 12

Study of Radiotherapy and Pembrolizumab in in People With Adrenocortical Carcinoma
Status: Active
Location: 7 locations
Mitotane with or without Cisplatin and Etoposide after Surgery in Treating Patients with Stage I-III Adrenocortical Cancer with High Risk of Recurrence
Status: Active
Location: 3 locations
Cabozantinib in Combination with Pembrolizumab for the Treatment of Patients with Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
Status: Active
Location: 3 locations
Cytoreductive Surgery and Heated Cisplatin in Treating Patients with Adrenocortical Cancer
Status: Active
Location: NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
Status: Active
Location: See ClinicalTrials.gov
A Phase 1 Study of [225Ac]-FPI-1434 Injection
Status: Active
Location: 2 locations
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
Pembrolizumab in Treating Patients with Rare Tumors That Cannot Be Removed by Surgery or are Metastatic
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas